Mass Tort Cases: Challenges for Plaintiff’s and Defense Counsel
Unlike conventional single event cases, mediation in mass tort cases can be more effective if the effort is applied ...
ResMed's SWOT analysis: sleep tech giant faces GLP-1 drug challenge
ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...
Sleep Apnea Therapy System Market Sustains 6.93% CAGR Growth, Expected To Hit 15.3 Billion USD By 2032
Sleep Apnea Therapy System Market. Key market drivers for Sleep Apnea Therapy System Market include rising prevalence of sleep apnea disorders, growing awa ...
ResMed's Moat Is Underpinned by Switching Costs and Intangible Brand Assets
Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...
ResMed targets 59-60% gross margins and expanded global reach for AirSense 11
CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and residential care software portfolios. Device sales, including AirSense 10 and ...
Future Market Insights5d
Sleep Apnea Devices Market to Reach USD 20.4 Billion by 2033 at a 9.5% of CAGR, Amid Rising Awareness and Technological Advancements
The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...